<DOC>
	<DOCNO>NCT01780519</DOCNO>
	<brief_summary>The investigator ' goal determine certain test memory attention , perform sleepiness induce single dose lorazepam , predict whether individual risk develop Alzheimer 's disease .</brief_summary>
	<brief_title>The Cognitive Effects Lorazepam Healthy Older Individuals With TOMM40 Variable-length Polymorphisms</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Lorazepam</mesh_term>
	<criteria>Inclusion criterion : MiniMental State Examination ( MMSE ) score 2830 Hamilton Depression Rating Scale score less 10 participant longitudinal study age TOMM40 genotype S/S , VL/VL , S/VL , L/S L/VL . Exclusion criterion : Alzheimer 's Disease Mild Cognitive Impairment significant medical , psychiatric , neurological illness , e.g. , impair liver kidney function , prior stroke , traumatic brain injury , memory impairment , cognitive impairment , parkinsonism , lifetime history schizophrenia , bipolar disorder , psychoactive substance use disorder , current major depression . know allergy benzodiazepine current use ( within previous four week ) benzodiazepine medication know interact lorazepam , current use sedating antihistamine , current use stimulant medication</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Alzheimer 's disease ( AD )</keyword>
</DOC>